Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Synergy Pharmaceuticals (SGYP) Ready To Roll

(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming months.



Synergy Pharmaceuticals (SGYP) ran to over seven dollars last month on increasing volume as the company's billion dollar potential took shape and numerous analysts jumped on board with encouraging write-ups and bold price predictions.



Synergy also received a boost when its chief competitor, Ironwood Pharmaceuticals (IRWD) received a setback at the FDA that allows SGYP an extra three months to play catch up in the race to commercialization for each company's respective product candidate, both of which target the same indication. Synergy's product Plecanatide, however, has a much more favorable side effect profile, making the Ironwood setback that much more of a key factor when discussing future market potential.



Both products, Synergy's Plecanatide and Ironwood's Linaclotide, are being developed to treat chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months, as mentioned before, while Phase II/III Plecanatide results are due out later this year.



The head start to market may provide Ironwood with a distinct advantage, but the advantage might not last too long when Plecanatide shows up on the scene.



During the Linaclotide trials, the drug was successful in alleviating symptoms relating to IBS-C and CIC when compared to a placebo, but the kicker is that patients experienced side effects that included cases of extreme diarrhea, essentially reversing the symptom being treated. Some cases of diarrhea were so bad that 6% of the patients decided to abandon the trial altogether.



On the open market - with a competing product out there for which there have been no such cases noted - that means those patients would likely switch to the alternative, in this case Plecanatide, that is not associated with carrying around a roll of Charmin' Soft at all times.



For full report visit: http://vfcsstockhouse.com/blog/article/-synergy-pharmaceuticals-sgyp-may-be-ready-to-roll



For full report and opinion visit: http://vfcsstockhouse.com/blog/article/-the-facebook-fb-ipo-don-t-believe-the-hype



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



For full disclaimer visit: http://vfcsstockhouse.com







VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Nearly 1 in 5 Trauma Patients in Chicago Area Treated in Ill-Equipped Hospita...
18 Jan 2017 at 5:55pm

With dramatic increases in shootings and homicides in Chicago in recent years, more and more patients are being taken to hospitals with traumatic injuries. Nearly one-fifth of patients who should have been taken to a designated level 1 trauma center from 2009 to 2013 were instead taken to community hospitals in the Chicago area that are not fully equipped to deal with these traumatic cases, according to a new study published today in JAMA Surgery. The city has long struggled with a lack of hospitals that are level 1 trauma centers, meaning they are designated specifically for the most serious types of traumatic injuries.


AP-NORC Poll: Americans of all stripes say fix health care
18 Jan 2017 at 4:33pm

Sylvia Douglas twice voted for President Barack Obama and last year cast a ballot for Democrat Hillary Clinton. But when it comes to "Obamacare," she now sounds like President-elect Donald Trump. ...


Blood pressure care in U.S. improving, but disparities remain
18 Jan 2017 at 4:11pm
By Andrew M. Seaman (Reuters Health) - Treatment of high blood pressure is improving in the United States, but a new study suggests white people are seeing more improvements than black or Hispanic people. Blacks and Hispanics were less likely to have their blood pressure under control, compared to whites, researchers found. The new study shows public health efforts to improve blood pressure control are working, but "there are still disparities that still affect minorities," said senior author Dr. Edgar Argulian, of Mt. Sinai St. Luke's Hospital in New York City.


FDA issues draft guidance to better medical product labeling
18 Jan 2017 at 3:56pm

(Reuters) - The U.S. health regulator issued draft guidance, recommending ways to communicate promotional materials and additional information that is not on the label of medical products. The U.S. Food and Drug Administration typically determines what information goes on the labels of medical drugs and devices, after evaluating whether the product is safe and effective for the proposed indication. If a firm communicates information, including on promotional material, that has not been evaluated by the regulator, but appears to be FDA-ratified, then it could lead to misbranding, and could subject firms to enforcement action if the representations or suggestions are considered false or misleading.


Startup League set for U.S. expansion, eyes next funding round
18 Jan 2017 at 3:56pm
By Solarina Ho TORONTO (Reuters) - League Inc, a Toronto-based startup that has excited investors because of its potential to streamline health benefits and the insurance market, will soon offer insurance products in the United States and complete its Canadian roll-out, its chief executive said on Wednesday. The two-year-old company is also eyeing overseas expansion and broadening its services this year, which could prompt another round of funding this fall or next spring, CEO and founder Michael Serbinis said in an interview. "Fall would be the first window to consider it." League lets businesses offer employees customized healthcare benefits through its app.


Father files suit against police in California for son's fatal shooting
18 Jan 2017 at 3:55pm

The father of Alfred Olango, an unarmed black man shot to death by police in Southern California last year, has filed a lawsuit against the officer involved and his department, accusing them of unjustly killing his son who was suffering from a mental breakdown. The slaying last September of Ugandan-born Alfred Olango, 38, in the San Diego suburb of El Cajon sparked several days of street protests after video of the deadly incident emerged online. The civil suit, filed on Friday in federal court in San Diego, came three days after local prosecutors announced that the officer who opened fire, Richard Gonsalves, would not be criminally charged for the shooting.



Canadian Pacific CEO Harrison to leave early
18 Jan 2017 at 3:50pm

Canadian Pacific Railway Ltd , Canada's No. 2 railroad operator, reported a lower-than-expected adjusted quarterly profit on Wednesday and said its chief executive would leave five months earlier than originally expected. Hunter Harrison will officially step down Jan. 31 and will take vacation leave with immediate effect. Last April, a company spokesman said Harrison planned to serve out his contract ending in June 2017.


Person-to-person contact may cause most drug-resistant TB cases
18 Jan 2017 at 3:04pm
By Gene Emery (Reuters Health) - The worst form of drug-resistant tuberculosis isn't just arising from inadequate treatment, it's mostly being spread from person to person, according to a new study of hundreds of cases in South Africa that has important implications for how the deadly disease is treated. Researchers tracked TB that is resistant to at least four key drugs and found that 69 percent of the victims had never received treatment, an indication that they had acquired it from others with extensively drug-resistant TB. "For many years, there was this thought that maybe drug-resistant TB strains might not be able to be transmitted as efficiently a regular TB strains," coauthor Dr. Neel R. Gandhi of Emory University?s Rollins School of Public Health in Atlanta told Reuters Health by phone.


Trump health pick defends stocks, says Americans won't lose insurance
18 Jan 2017 at 2:47pm

By Toni Clarke and Susan Cornwell WASHINGTON (Reuters) - President-elect Donald Trump's nominee to head the U.S. Department of Health and Human Services defended his stock holdings and proposals to dismantle Obamacare on Wednesday, saying Americans would not suddenly lose health insurance. Representative Tom Price told the Senate Committee on Health, Education, Labor and Pensions, one of two that oversee the health department, that there was no connection between his purchase of certain health company stocks and his promotion of legislation that would have helped the companies.



Business euphoria over Trump gives way to caution, uncertainty
18 Jan 2017 at 2:21pm

By Patrick Rucker and Sarah N. Lynch WASHINGTON (Reuters) - Early optimism among business lobbyists and executives that Donald Trump's election heralded better days has slowly given way to uncertainty as the president-elect fires off mixed and sometimes confusing messages on healthcare, taxes and trade. Some of that has frayed as questions arise over the nuts and bolts of Trump's campaign promises, although many in the business community said they remained optimistic. Doubts deepened over the weekend as Trump declared he would replace President Barack Obama's signature healthcare plan known as Obamacare with "insurance for everybody" - a goal far beyond Republican designs - and criticized a key component of a plan in Congress to overhaul corporate taxes.


Price tries to reassure on health care; Dems not buying it
18 Jan 2017 at 2:16pm

Offering reassurances, President-elect Donald Trump's pick for health secretary said Wednesday the new administration won't "pull the rug out" from those covered by "Obamacare." Democrats ...



Global coalition aims to outpace epidemics with new vaccines
18 Jan 2017 at 2:03pm

By Kate Kelland DAVOS, Switzerland (Reuters) - A global coalition of governments, health specialists and philanthropists will launch a new plan on Thursday to "outsmart" future disease epidemics with a fund to prepare and create new vaccines. Stung by the devastation of West Africa's 2014-2015 Ebola outbreak, which killed more than 11,300 people before an effective vaccine was developed, the coalition is aiming to ensure such deadly outbreaks can't happen again. John-Arne Rottingen, interim chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI), said it is designed as "a global insurance policy against epidemic and pandemic threats".



Successful pregnancy possible even with heart defects
18 Jan 2017 at 1:57pm

By Lisa Rapaport (Reuters Health) - Women who are born with high-risk heart defects can have successful pregnancies if they get the right medical support, according to new U.S. guidelines. The guidelines are the first from the American Heart Association to offer a road map to women with congenital heart defects who have long been told to avoid pregnancy altogether, said Mary Canobbio, a researcher at the University of California, Los Angeles and chair of the committee that drafted the advice. ?Historically the tendency has been to advise these women to avoid pregnancy because the defect and surgeries done to keep these women alive are complex and the long term survival is difficult to predict ? so concern has been that the ?added burden? of pregnancy could potentially cause more problems and decrease their own long term survival,? Canobbio said by email.



Vape companies try to galvanize Trump administration to ease FDA rules
18 Jan 2017 at 12:55pm

As tobacco and vaping companies focus on new smoking products that are potentially less harmful, the industry sees an opening for rolling back rules on these products under the Trump administration. Donald Trump?s surprise election victory in November, and his pledges to reduce federal regulations on business, led tobacco lobby groups to draft a new plan of action, according to company executives, lobbyists and consultants interviewed by Reuters. The immediate goal is to delay implementation of new regulations on the latest generation of e-cigarettes and other vaping devices, which produce a vapor from liquid nicotine rather than burning tobacco.



Flabby heart keeps pumping with squeeze from robotic sleeve
18 Jan 2017 at 12:33pm

WASHINGTON (AP) ? Scientists are developing a robotic sleeve that can encase a flabby diseased heart and gently squeeze to keep it pumping.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC